What Researchers Did
Researchers reported a rare case of combined central retinal artery and vein occlusion in a patient with Factor V Leiden mutation treated with hyperbaric oxygen therapy.
What They Found
A 49-year-old woman with combined central retinal artery and vein occlusion and Factor V Leiden mutation initially improved from a best corrected visual acuity (BCVA) of 1/20 to 10/10 after hyperbaric oxygen therapy. However, her vision later declined to <1/20 due to a new central retinal vein occlusion, eventually stabilizing at 6/10 after bevacizumab injections.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a broader patient population.